Related Experiment Video
Updated: Jul 17, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
Cellular transplantation: future therapeutic options
Rebecca Allan1, Malek Kass, Christopher Glover
1Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Purpose Of Review:
Cardiac transplantation is a complex undertaking and an imperfect solution to end-stage heart failure. Cellular transplantation has been proposed as an alternative solution; however, clinical trials at present are small and show variable results. The mechanisms behind stem cell therapy have not yet been elucidated.
Recent Findings:
Several large trials have been presented that address the question of bone marrow stem cells as therapy for acute myocardial infarction, and also the possible benefits of therapy with granulocyte colony-stimulating factor. Although some trials show a modest improvement in ejection fraction or reduction of infarct size, other trials show no change with treatment. Fewer clinical data are available on the treatment of chronic left ventricular systolic function. Many questions remain such as what cell type to use, dosing, the ideal timing for therapy, and the technique of cell delivery. Finally, further research continues on the cellular milieu, enhancement of cell engraftment, proliferation, and survival.
Summary:
This review briefly examines the background for stem cell therapy, as well as the larger clinical trials of stem cell therapy for acute myocardial infarction and chronic left ventricular systolic dysfunction, and possible pharmacologic enhancement options.
Insights
Stem cell therapy shows variable results for heart failure patients. Further research is needed to determine optimal cell types, dosing, and delivery methods for effective treatment.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Cardiac transplantation is a complex procedure for end-stage heart failure.
- Cellular transplantation is an emerging alternative, but clinical trials yield inconsistent outcomes.
- The precise mechanisms of stem cell therapy in cardiac repair remain unclear.
Purpose of the Study:
- To review the background of stem cell therapy for cardiac conditions.
- To examine large clinical trials investigating stem cell therapy for myocardial infarction and heart failure.
- To explore potential pharmacologic enhancements for stem cell therapy.
Main Methods:
- Review of large clinical trials on bone marrow stem cells and granulocyte colony-stimulating factor for acute myocardial infarction.
- Analysis of available clinical data for chronic left ventricular systolic dysfunction.
- Discussion of ongoing research into cellular mechanisms, engraftment, proliferation, and survival.
Main Results:
- Clinical trials for acute myocardial infarction show mixed results, with some indicating modest improvements in ejection fraction or infarct size, while others show no significant benefit.
- Limited clinical data exists for treating chronic left ventricular systolic dysfunction with stem cells.
- Key questions regarding optimal cell type, dosage, timing, and delivery methods persist.
Conclusions:
- Stem cell therapy for cardiac conditions requires further investigation.
- Significant challenges remain in optimizing cell type, delivery, and engraftment for therapeutic success.
- Future research should focus on elucidating mechanisms and refining treatment protocols.
More Related Videos
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Stem Cell Culture

